![Mark Engel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profil
Mark Engel is the founder of Excel PharmaStudies, Inc. Mr. Engel is currently the Chairman & Chief Executive Officer of Phagelux, Inc., the Chairman & Chief Executive Officer of Precisio Biotix Therapeutics, Inc., and the Chairman of Phagelux (Canada), Inc.
Aktive Positionen von Mark Engel
| Unternehmen | Position | Beginn |
|---|---|---|
Excel PharmaStudies, Inc.
 Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory, clinical research and quality assurance services | Gründer | - |
Phagelux, Inc.
 Phagelux, Inc. BiotechnologyHealth Technology Manufactures anti bacteriophages, lytic enzymes and new drug delivery systems | Vorstandsvorsitzender | - |
Phagelux (Canada), Inc.
 Phagelux (Canada), Inc. BiotechnologyHealth Technology Developing anti bacterial phage based solutions | Vorsitzender | 11.03.2015 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
5
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Excel PharmaStudies, Inc.
Excel PharmaStudies, Inc. Miscellaneous Commercial ServicesCommercial Services Provides regulatory, clinical research and quality assurance services | Commercial Services |
Phagelux, Inc.
Phagelux, Inc. BiotechnologyHealth Technology Manufactures anti bacteriophages, lytic enzymes and new drug delivery systems | Health Technology |
Phagelux (Canada), Inc.
Phagelux (Canada), Inc. BiotechnologyHealth Technology Developing anti bacterial phage based solutions | Health Technology |
